Correlation of histologic features with gene alterations in pleural mesothelioma Journal Article


Authors: Fanaroff, R. E.; Yang, S. R.; Tan, K. S.; Adusumilli, P. S.; Bodd, F.; Bowman, A.; Chang, J.; Offin, M. D.; Reiner, A.; Rekhtman, N.; Rusch, V. W.; Travis, W. D.; Zauderer, M. G.; Ladanyi, M.; Sauter, J. L.
Article Title: Correlation of histologic features with gene alterations in pleural mesothelioma
Abstract: Histologic features, including architectural patterns, cytologic features, and 2021 World Health Organization nuclear grade have been shown to have prognostic significance in epithelioid diffuse pleural mesothelioma (DPM). Biphasic and sarcomatoid DPM, regardless of morphology, have worse outcomes. These prognostic findings are well established but the correlation of architectural patterns, cytologic features, and nuclear grade with genetic alterations has not been well studied. To investigate relationships between histologic findings and genomic alterations, 128 treatment-naïve DPM specimens (70% epithelioid, 23% biphasic, and 6.3% sarcomatoid) with next-generation sequencing data were retrospectively reviewed. Alterations in BAP1 were the most common genomic alteration (n = 62, 48%), followed by CDKN2A (n = 49, 38%) and NF2 (n = 38, 30%). NF2 alterations were significantly more frequent in biphasic DPM (53% in biphasic vs 25% in sarcomatoid and 22% in epithelioid DPM; P = .005). In epithelioid DPM, TP53 alterations were associated with the presence of prognostically unfavorable histology, including micropapillary or solid architecture, pleomorphic features, and high nuclear grade. Tumors with low tumor-infiltrating lymphocytes (TILs) had a higher rate of BAP1 alterations than tumors with higher levels of TILs (67% vs 30%; P = .002). The findings of this study enhance our understanding of the relationships among prognostically significant histologic and molecular features of DPM and provide preliminary data to support increased integration of these findings in clinical diagnosis of pleural mesothelioma. © 2025 The Authors
Keywords: adult; controlled study; human tissue; aged; unclassified drug; gene mutation; human cell; histopathology; cancer grading; tumor associated leukocyte; protein; cohort analysis; retrospective study; protein p53; pleura mesothelioma; cyclin dependent kinase inhibitor 2a; merlin; cdkn2a; nf2; tp53; bap1; brca1 associated protein 1; cancer prognosis; high throughput sequencing; setd2; human; male; female; article; diffuse pleural mesothelioma; biphasic pleural mesothelioma; sarcomatoid pleural mesothelioma
Journal Title: Modern Pathology
Volume: 38
Issue: 5
ISSN: 0893-3952
Publisher: Nature Research  
Date Published: 2025-05-01
Start Page: 100706
Language: English
DOI: 10.1016/j.modpat.2025.100706
PUBMED: 39788204
PROVIDER: scopus
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged on PDF -- MSK corresponding author is Jennifer Sauter -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    424 Rekhtman
  2. Valerie W Rusch
    864 Rusch
  3. Marc Ladanyi
    1326 Ladanyi
  4. William D Travis
    742 Travis
  5. Marjorie G Zauderer
    188 Zauderer
  6. Jason Chih-Peng Chang
    133 Chang
  7. Kay See   Tan
    241 Tan
  8. Michael David Offin
    170 Offin
  9. Jennifer Lynn Sauter
    124 Sauter
  10. Anita S Bowman
    44 Bowman
  11. Francis M Bodd
    21 Bodd
  12. Soo Ryum Yang
    75 Yang
  13. Allison Joyce Reiner
    5 Reiner